4Gokbuget N, Hoezler D. Treatment of adult acute lymphoblastie leukemia. Hematology, 2006: 133-141.
5Cassileth PA, Andersen JW, Bennett JM, et al. Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience. Leukemia, 1992,6(suppl 2):178-181.
6Larson RA, Dodge RK, Linker CA, et al. A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute tymphohtastic leukemia: CALGB study 9111. Blood, 1998,92(5) :1556-1564.
7Rowe JM, Buck G, Burnett AK, et al. Induction therapy for adults with acute lymphohlastie leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood, 2005, 106(12):3760-3767.
8Kantarjian H, Thomas D, O'Brien S, et al. Long-term follow-up results of hyperfractionated cyclophosphamide vincristine, doxorubicin, and dexamethasone ( Hyper-CVAD ), a doseintensive regimen, in acute lymphoblastic leukemia. Cancer, 2004, 101(12):2788-2801.
9Boissel N, Audere MF, Lheritier V, et al. Should adolescents with aeute lymphoblastie leukemia be treated as old ehildren or young adults? Comparison of the Freneh FRALLE-93 and LALA-94 trials. J ClinOneol, 2003, 21(5):774-780.
10Barry E, DeAngelo DJ, Neuberg D, et al. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute lymphoblastic Leukemia Consortium Protocol. J Clin Oncol, 2007, 25(7):813-819.
